Literature DB >> 365776

Therapy of serious infections with cefamandole.

M F Parry, M J Goldberger, H C Neu.   

Abstract

Forty-four patients with serious bacterial infections were treated with cefamandole in a dose 1--2 g every four to six hours. Thirty-two patients were cured and six were markedly improved. Three of six failures were due to superinfection with cephalothin-resistant microorganisms. The over-all bacteriologic response was 80%. In 12 of 13 patients with bacteremia the blood was sterilized. Ten of 14 patients with gram-negative bacillary infections responded to treatment. Six of these were due to cephalothin-resistant microorganisms, three of which responded. Fifteen patients who were treated had a history of penicillin allergy. There were no serious reactions although skin rash did develop. Phlebitis was uncommon.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365776     DOI: 10.1007/bf01642316

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.

Authors:  R N Jones; P C Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

2.  Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.

Authors:  S Berger; E C Ernst; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

3.  Cefamandole and ampicillin therapy in experimental Haemophilus influenzae meningitis.

Authors:  L J Strausbaugh; C D Mandaleris; M A Sande
Journal:  J Infect Dis       Date:  1977-02       Impact factor: 5.226

4.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

5.  Pharmacokinetics of cefamandole in the presence of renal failure in patients undergoing hemodialysis.

Authors:  G B Appel; H C Neu; M F Parry; M J Goldberger; G B Jacob
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

  5 in total
  1 in total

Review 1.  The cephalosporins: activity and clinical use.

Authors:  A J Weinstein
Journal:  Drugs       Date:  1980-08       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.